Clinical Trial Detail

NCT ID NCT02397083
Title Phase II Study of Intrauterine Device (IUD) Alone or in Combination With Everolimus in Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

endometrial carcinoma

Therapies

Everolimus

Age Groups: adult

No variant requirements are available.